The Ministry of industry and trade of the Russian Federation
FSI «SID & GP»
+7 (495) 676-43-60 109044, Moscow, Lavrov lane., 6
The Director of SID & GP opened a new manufacturing site in Nizino
Export potential of Russian pharmaceuticals has been discussed at the SPIEF
By 2022, SID & GP will have developed several pediatric dosage forms
Good practices in drug quality assurance from development to the consumer

About institute

State Institute of Drugs and Good Practices

The Federal State Institution «State Institute of Drugs and Good Practices» (also known as FSI «SID & GP») is a subordinate agency of the Russian Ministry of Industry and Trade. The Institute was founded in 1973. For more than 40 years, the Institute has been a major research facility in the field of pharmacy.

In 2013, the FSI «SID & GP» received accreditation as an expert organization for licensing control of pharmaceutical manufacturers during inspections conducted by the Russian Ministry of Industry and Trade.

In 2015, FSI «SID & GP» was authorized to conduct GMP inspections of pharmaceutical products for human use produced outside of the Russian Federation, to issue compliance verifications of pharmaceutical manufacturers with the GMP requirements.

The Institute is Headed by Vladislav Shestakov.

Latest news

Within the Saint Petersburg International Economic Forum, a formal opening of a new manufacturing site «Severnaya Zvezda» took place.
At this year's Saint Petersburg International Economic Forum, special consideration is given to the topics of pharmaceuticals, medicine, and healthcar…
In Kazan, the 1st All-Russia Pharmaceutical Car Race dedicated to the topic «National objectives in healthcare. The development issues of priority» wa…
On 18 May, within the IX International Legal Forum in Saint Petersburg, the «Pharmaceutical industry» track at the «Drug circulation» session was the…
At the Second International Industrial Exhibition EXPO-RUSSIA Uzbekistan 2019, the Deputy Head of the Russian state GMP inspectorate Mr. Vladislav She…
The topic of the pharmaceutical quality system being an integral part of the entire drug manufacturing process, the peculiarities of its implementatio…
In Beijing, a meeting between the Russian state GMP inspectorate and the Chinese regulator CFDI (Center for Food and Drug Inspection) was held. As a f…
This day in the morning, the 2nd annual Moscow city conference dedicated to the topical issues of clinical pharmacology and pediatrics «The Drug and t…
Not only pharmaceutical companies of the EAEU member countries are reaching after obtaining an EAEU GMP certificate – the process is starting to invol…
At the 2nd conference «Information technologies in pharmacy: the pahramceutical industry on its way to digital transformation», SID & GP announced dra…

Our partners